Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 12:50 PM ET

Date/Time Source News Release
12/23/2024 09:00 AM EST PR Newswire NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS
12/18/2024 10:25 AM EST PR Newswire NeuroSense Provides Business Update and Third Quarter 2024 Financial Results
12/11/2024 09:25 AM EST PR Newswire NeuroSense Receives Positive FDA Feedback on Phase 3 Study Design for PrimeC
12/04/2024 08:30 AM EST PR Newswire NeuroSense Announces Completion of PARADIGM Study Highlighting PrimeC's Significant Efficacy and Survival Benefits in ALS
12/02/2024 08:30 AM EST PR Newswire NeuroSense Therapeutics Announces $5 Million Private Placement at Premium to Market Price
11/21/2024 09:20 AM EST PR Newswire NeuroSense Therapeutics to Participate in the 2024 International Symposium on ALS/MND
10/28/2024 08:30 AM EDT PR Newswire NeuroSense Secures Key FDA Meeting to Advance its Phase 3 ALS Trial and NDA Submission
10/24/2024 08:30 AM EDT PR Newswire New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients
10/15/2024 09:15 AM EDT PR Newswire NeuroSense Advances Plans for Early Commercialization of Groundbreaking ALS Treatment in Canada, Provides Further Updates
10/09/2024 09:00 AM EDT PR Newswire NeuroSense Therapeutics Plans to File for Early Commercialization of ALS Treatment in Canada
Page

Additional News

As of January 3, 2025 • 12:50 PM ET

Date/Time Source News Release
12/26/2024 04:56 PM EST SeekingAlpha NeuroSense Therapeutics files to sell 5.28M ordinary shares for holders
12/17/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, December 17th, 2024
12/17/2024 04:31 AM EST US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
12/10/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, December 10th, 2024
12/10/2024 04:30 AM EST US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
12/06/2024 04:51 PM EST SeekingAlpha NeuroSense Therapeutics files for 6.6M ordinary shares for holders
12/02/2024 09:14 AM EST SeekingAlpha NeuroSense Therapeutics shares climbed on $5M private placement
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
09/24/2024 09:09 AM EDT SeekingAlpha NeuroSense regains compliance with minimum bid price rule
08/30/2024 05:28 PM EDT SeekingAlpha NeuroSense Therapeutics receives Nasdaq minimum bid price notification
Page